Starpharma (ASX:SPL) granted marketing approval for condom in Europe

Company News

by Rachael Jones

Starpharma (ASX SPL) has been granted marketing approval for the VivaGel® condom in Europe.

It is the only condom of its type incorporating the proprietary compound, astodrimer sodium (SPL7013, VivaGel®) in the condom lubricant.

The European approval applies to all 28 member states of the European Union, including the United Kingdom, a total population of approximately 525 million people.

Starpharma’s marketing partner in Europe, LifeStyles (formerly Ansell) will now undertake marketing preparations ahead of the launch under the brand name Absolute™ DUAL PROTECTION.

The VivaGel® condom is also approved for sale in Japan, Canada and Australia.

Shares in Starpharma (ASX SPL) closed 1.54 per cent higher at $1.32
 

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.